Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 2/20 | 0.39 |
| ▸ | NRP1 | O14786 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 11/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 8/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | PDE9A | O76083 | 1/20 | 0.34 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20596602 | 1.00 | SERPINE1 (0.39) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL20596563 | 0.95 | SERPINE1 (0.37) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL16127333 | 0.93 | SERPINE1 (0.39) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL16127443 | 0.93 | KIF11 (0.40) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL16127405 | 0.93 | KIF11 (0.40) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL21437177 | 0.93 | SERPINE1 (0.37) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL20596389 | 0.92 | HTR3A (0.38) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL20596470 | 0.92 | HTR3A (0.38) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL20596487 | 0.91 | SERPINE1 (0.37) | SERPINE1NRP1KDM4EMAPTNPSR1 | |
| SCHEMBL21950680 | 0.91 | NRP1 (0.40) | SERPINE1NRP1KDM4EMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-04-25 | — | — | US | disclosed |
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
| WO-2018237389-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux Inc. (JP) | 2018-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, CLTB, CYBA | SERPINE1 4579/4885NRP1 992/4885KDM4E 3854/4885 |
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, CLTB, CYBA | SERPINE1 4579/4885NRP1 992/4885KDM4E 3854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.